两名MLN-TK患者有ETV::ABL1融合,通过不同的机制调解,具有假负FISH结果,通过RNA融合分析得到解决

Patrick Maher1, Tim Jang2, Ruben Ruiz Vega3

  • 1University of Florida, Department of Pathology, Immunology, and Laboratory Medicine, Gainesville, FL, USA.

Cancer genetics
|July 6, 2025
PubMed
概括

骨髓/淋巴瘤瘤与氨酸激酶融合 (MLN-TK) 涉及ETV6:ABL1基因融合存在诊断挑战. 准确的RNA融合分析对于正确的诊断和治疗至关重要,特别是当还检测到BCR::ABL1时.

相关概念视频